Rania El-Botty et al.
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-40022-5
Rania El-Botty et al.
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-40022-5